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ABSTRACT
Background: Some patients with Japanese cedar (JC) pollinosis already show pollinosis symptoms before
the first day of the pollen season as determined by microscopic pollen counts.
Methods: Airborne pollen allergen (Cry j 1) levels were measured by electron spin resonance radical immu-
noassay, a highly-sensitive method for Cry j 1 with a sensitivity 10―100-fold higher than conventional enzyme-
linked immunosorbent assay. The symptom data from patients with JC pollinosis were collected from a mobile
phone site, “pollen check sheet”, and the onset times of the patients’ symptoms were analyzed.
Results: The relationship between airborne Cry j 1 levels and the onset time of pollinosis symptoms was in-
vestigated. The symptoms of some patients began at the time airborne Cry j 1 levels fluctuated at 1 to 3 pgm3
and symptom scores increased at the time of sudden increase in Cry j 1 levels. About 40% of patients began to
show symptoms until the first day of the pollen season and the time nearly corresponds to the time of sudden
increase in Cry j 1 levels.
Conclusions: Pollinosis symptoms of some patients began at the time airborne Cry j 1 levels fluctuated at 1
to 3 pgm3 and symptom scores increased at the time of sudden increase in Cry j 1 levels. The latter time
nearly corresponds to the first day of the pollen season.
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INTRODUCTION
Patients can take prophylactic measures (medication)
against the symptoms of pollinosis if it is possible to
predict the onset of their symptoms before they are
observed.1-6 In the case of Japanese cedar (JC) polli-
nosis, the first day of the pollen season is defined as
the first day when a certain amount of JC pollen is de-
tected in the air by microscopic pollen counts (one or
more pollen grains per cm2 for not less than 2 days
collected with a Durham sampler (Nishiseiki Co.
Ltd., Funabashi-City, Japan)).7 However, it is widely
known that some patients experience pollinosis
symptoms before the first day of the pollen season.1,2
If very small amounts of Cry j 1 could be quantified,
this could be used to estimate the onset time of symp-
toms in some patients. For the quantification of air-
borne Cry j 1, we applied electron spin resonance
(ESR) radical immunoassay, which was developed as
a highly-sensitive method for detecting hepatitis B vi-
rus antigen.8,9 In our previous study, we clarified that
the sensitivity of the immunoassay is 10―100-fold
higher than that of conventional enzyme-linked im-
munosorbent assay (ELISA).10 By using this analyti-
cal method, it might be possible to inform patients of
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METHODS
SAMPLING AND ANTIGEN EXTRACTION
A cyclone sampler, CM 90 from Burkard Co. Ltd
(Rickmansworth, UK) was installed in Iwanami in
Yamagata-City and airborne pollen antigens were col-
lected during the periods February 23 to April 24,
2003; February 23 to April 24, 2004; January 23 to
May 11, 2005; and February 12 to June 26, 2006. Air-
borne particles greater than 1 μm in diameter were
collected in 1 mL tubes. The tubes were changed at
06 : 00, and collected at 24-hour intervals. The anti-
gens in the airborne samples were extracted with 100
μL of 0.125 M ammonium bicarbonate in 0.1% bovine
serum albumin for 2 hours at room temperature.
MEASUREMENT OF CRY J 1 WITH ESR RADI-
CAL IMMUNOASSAY METHODS
Anti-Cry j 1 monoclonal antibody (013) (Hayashibara
Biochemical Laboratories, Inc. Okayama-City, Japan)
was diluted to 10 μgmL with phosphate buffer (PB;
0.1 M and pH 7.0). The diluted antibody (100 μL)
was put in a 96-well Nunc plate (Nunc-immuno Mod-
ule 469949, Nunc Co. Ltd. Kamstrupvej, Denmark)
and reacted for 6 hours at 4℃. After three washes
with ultra-pure water, 370 μL of Stabilguard (SurMod-
ics, Inc., Minneapolis, MN, USA) was placed in each
well and blocked overnight at 4℃ (Cry j 1-coated
plate). After washing with pure water, the plates were
placed in a desiccator until use, and kept at 4℃.
Measurements were done as follows. Seven different
concentrations of Cry j 1 standard solution (twofold
dilution from 15.6 pgmL to 1,000 pgmL with 10% fe-
tal bovine serum (FBS; ThermoTrace Ltd., Mel-
bourne, Australia), 0.1 M PB (pH 7.0)) were prepared
each time prior to measurement. A standard solution
(100 μL) of 10% FBS and 0.1 M PB (100 μL) were
placed in each well of the anti-Cry j 1 monoclonal
antibody-coated plate, and then 0.125 M ammonium
bicarbonate (30 μL) or an airborne sample (30 μL)
was added. Horseradish peroxidase-conjugated anti-
Cry j 1 monoclonal antibody (053) (Hayashibara Bio-
chemical Laboratories, Inc., Okayama-City, Japan) di-
luted with 10% FBS, 0.1 M PB was added to each well
and mixed thoroughly. The plate was left for 1 hour
at room temperature. After several washings with
ELSIA-F washing solution, 150 μL of 4 mM p-
acetamidophenol and 0.34 mM 1-hydroxy-2, 2, 5, 5-
tetramethyl-3-imidazoline 3-oxide and 0.01% hydrop-
eroxide were added and reacted for 1hour at 37℃.
The enzyme reaction was stopped with 50 μL sodium
azide (100 mM). The amount of nitroxide radical (sta-
ble radical) obtained as a result of the enzyme reac-
tion was measured with an electron spin resonance
device (ESR: FR30 and JEOL). Details of the ESR
measurement were reported elsewhere.8,9
SYMPTOM SCORES
Symptom data from anonymous JC pollinosis patients
who had access to the mobile phone site “pollen
check sheets” supplied by Weathernews Co. Ltd.
were used. The sheets are on a personal site which
can be accessed with a user I.D. and password by mo-
bile phone. A remarkable feature of the sheets is
their easiness in keeping a record of everyday symp-
toms because the record is managed through mobile
phones that users always carry. It is like an electronic
version of a pollen diary. The user obtains the right
information and proper measures in order to input
everyday symptoms by use of a two-way communica-
tion system. First, people living in Yamagata prefec-
ture or Tokyo were extracted using point numbers of
the Automated Meteorological Data Acquisition Sys-
tem (AMeDAS) station from an enormous amount of
data on “pollen check sheets” collected from the
whole of Japan (ca. 190,000 accesses in total in 2003).
The point number of the nearest AMeDAS station is
necessary for information and measures for each
user, and therefore all the point numbers were as-
signed based on reported addresses. People who
used the mobile phone site for the first time were
asked whether they had been given a “diagnosis of
JC pollinosis in a clinichospital” and “when they no-
ticed pollinosis symptoms after new year’s day”. In
our study, only patients who replied to have received
a “diagnosis of JC pollinosis in a clinichospital” were
extracted and the extracted patients were regarded
as JC pollinosis patients in this paper. The extracted
data belonging to Tokyo were classified by age and
used as control of an urbanized area for age distribu-
tion in Figure 2. The data belonging to Yamagata
were arranged in the necessary order: time sequence
and age.
The symptom data consisted of four symptom
scores. They are self-assessed four-point severity
scale subjective symptom scores, namely, sneezing,
blowing one’s nose, nasal blockage, and itching of the
eyes, according to Okuda’s criteria.11 The scores
used for the analysis are shown in Table 1. The mean
scores for each day were calculated by adding the
four subjective symptoms together day by day. The
mean scores for each day in Figure 3C were calcu-
lated by adding the four subjective symptoms of all
accesses together day by day. Then they were di-
vided by the numbers of accesses on each day to ob-
tain the total scores for each access. The mean scores
of the four subjective symptoms were finally calcu-
lated by dividing the total scores for each access by
four. The data used for the analysis comprised 83 pa-
tients (41% men and 59% women) in 2003 (Feb 1―Mar
20), 25 patients (36% men and 64% women) in 2004
(Feb 12―Mar 23), 53 patients (38% men and 62%
women) in 2005 (Feb 1―Mar 17), and 13 patients (31%
men and 69% women) in 2006 (Feb 10―Mar 10).
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Table 1 Subjective symptom scores from the polen check 
sheets
ScoreSneezing
How many times did you sneeze today?
0: None
1: More than one time
2: More than 6 times
3: More than 11 times
4: More than 21 times
Blowing one’ snose
How many times did you blow your nose today?
0: None
1: More than one time
2: More than 6 times
3: More than 11 times
4: More than 21 times
Nasal blockage
What was the degree of your nasal blockage?
0: My nose wasn’ tclogged
1: Breathing through my nose was easy
2: I could sometimes not breathe through my 
nose
3: It was always hard to breathe through my 
nose
4: I could not breathe through my nose, and I 
could not endure it
Itching of the eyes
How itchy were your eyes?
0: No itchiness
1: Not as much as to rub my eyes
2: I sometimes rubbed my eyes
3: I rubbed my eyes extensively
4: Unbearably itchy
Fig. 1 Standard  curve  obtained  from  ESR  radical
immunoassay. The vertical axis indicates the signal intensity 
measured by ESR. The intensity is expressed in arbitrary 
(au) unit measured at 336.1 ± 5 mili Tesla (mT) as a center 
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Fig. 2 Age distribution of JC polinosis patients in Yama




















A standard curve obtained from ESR radical immu-
noassay is shown in Figure 1. The vertical axis indi-
cates the signal intensity measured by ESR and the
horizontal axis indicates Cry j 1 levels expressed in
pgmL. The detection limit, which was defined as 1.5-
fold of blank signal intensity, was estimated to be 3.5
pgmL and it is possible to measure 0.1 pg Cry j 1 in
a sample which needs 30 μL for each measurement.
Figure 2 (a) shows the age distribution of JC polli-
nosis patients in Yamagata in 2003. Figure 2 (b)
shows the age distribution in Tokyo in 2003 as com-
parison. Most of the data obtained from the “pollen
check sheets” were from patients in their 20’s to 30’s.
In Tokyo in particular, 81.2% of patients belonged to
these generations. On the other hand, a slightly older
age distribution was seen in Yamagata and 88.2% of
patients were in their 20’s to 40’s. Similar age distri-
butions were seen in Yamagata in the other 3 years.
Table 2 summarizes the 4-year results of the first
day of reported pollinosis symptoms, the first day of
the pollen season, and the first day of airborne Cry j 1
reaching a certain value in 2003 to 2006. About 40% of
JC pollinosis patients using the site “pollen check
sheets” showed pollinosis symptoms before the first
day of the pollen season. Some of the patients began
to show symptoms more than 1 month before the
first day of the pollen season, on days distributed be-
tween late January and early-to-middle February. Cry
j 1 levels reached 1 pgm3 2―3 weeks before the first
day of the pollen season. Figure 3 (a) to Figure 3 (d)
indicate the relationship between airborne Cry j 1 lev-
els in pgm3 and mean symptom scores of JC pollino-
sis patients before and after the first day of the pollen
season in 2003 and 2006. The symptoms of some pa-
tients already began at the time Cry j 1 levels fluctu-
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Table 2 Results of the first day of polinosis symptoms reported, the first day of the polen season and the first day of airborne 
Cry j 1 reaching a certain level for each year.
2006200520042003Year
26-Jan26-Jan12-Feb2-Feb(1) The first day polinosis symptoms appeared in some patients
7-Mar11-Mar12-Mar11-Mar(2) The first day of the polen season
35.1%42.2%42.6%40.5%(3) Rates of patients who showed symptoms before the first day
7-Mar11-Mar17-Mar15-Mar(4) The first day of Cry j 1 reaching approximately 5 pg/m3
27-Feb11-Mar11-Mar1-Mar(5) The first day of Japanese cedar polen observed by microscopy
13-Feb24-Jan24-Feb24-Feb(6) The first day of Cry j 1 reaching approximately 1 pg/m3
Fig. 3 Relationship between airborne Cry j 1 levels in pg/mL, the numbers of subjects and mean symptom scores of JC 
polinosis patients in 2003 to 2006. The vertical arow indicates the first day of the polen season by microscopic polen 
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Table 3 The total amounts of Cry j 1 and total JC polen counts during the polen season.
2006200520042003Year
20.355.9 1.5  14.3 (1) The total amounts of Cry j 1 during the polen season (ng/m3)
129253336542280(2) The total JC polen counts during the polen season (grains/cm2)＊＊
63.695.4436159.4(3) Ratio of (2)/(1)
Research periods for each year are as folows; Feb 23 to Apr 24, 2003; Feb 23 to Apr 22, 2004; Jan 23 to May 10, 2005; and Feb 12 
to May 9, 2006.
＊＊Oficialy announced values counted by Durham sampler
ated at 1 to 3 pgm3 in the air. After that, the time of
increase in the symptom scores corresponded to that
of sudden increase in Cry j 1 levels. The first days of
the pollen season in 2003 and 2006 nearly corre-
sponded to the time of sudden increase in Cry j 1 lev-
els. There were 20 to 60 accesses per day in 2003, the
first year of the information service. The accesses de-
creased gradually, and there were some days without
any access in 2006.
The total amounts of Cry j 1 during the pollen sea-
son are shown in Table 3. There are large yearly dif-
ferences from 1.5 ngm3 (2004) to 55.9 ngm3 (2005).
It is calculated that 1.5 ng of Cry j 1 is equivalent to
300 JC pollen grains and 55.9 ng to 11,180 JC pollen
grains, if the amount of Cry j 1 in a pollen grain is as-
sumed to be 5 pg. A correlation was seen between
the total pollen counts by microscopy and the total
Cry j 1 amounts during the pollen season investigated
over 4 years (r = 0.953, p < 0.05). However, at most a
7-fold difference was seen among the ratio of these
two values.
DISCUSSION
Pollinosis diaries have been widely used to analyse
the symptoms of pollinosis patients. However, these
allow acquisition of data on symptoms only after the
day a patient visits the clinician, unless asked in ad-
vance. Investigation using pollinosis diaries was not
considered feasible for early-stage symptoms, which
were the object of this study, because most patients
do not come to visit the clinichospital during our tar-
get period. The advantages of the method used in
this study include the ease of inputting everyday
symptoms one after another by mobile phone and the
possibility of obtaining data from various patients
who do not visit their clinician often. Regarding fixed
diagnosis such as with specific IgE antibody examina-
tion (RAST test), patients at large hospitals, such as
university hospitals, are examined with various reli-
able tests before being given a diagnosis of JC polli-
nosis; however, most patients visited clinics or small-
scale hospitals where such reliable tests are not con-
ducted to establish a diagnosis of JC pollinosis. Our
symptom data do show some bias regarding diagno-
sis, sex (a majority of women), and age (a majority of
young patients; 20’s to 40’s). We must keep this in
mind when analyzing the data. It is considered,
though, that our results are useful for mobile phone
users, as far as the information supplied through mo-
bile phones is concerned. Recently, Okubo et al. in-
vestigated the efficacy and safety of Omalizumab in
the treatment of JC pollen-induced seasonal allergic
rhinitis.12 In their study, patients needed to be care-
fully chosen to only include JC pollinosis patients.
Our aim is the improvement of pollen information
and examination of the validity, so we tried to collect
many data from various patients who did not visit
their clinician often.
It is well known that JC pollinosis patients who
start their medication several weeks before the first
day of the pollen season can spend the pollen season
without severe symptoms.1-6 It was indicated from
our study that Cry j 1 levels reached 1 pgm3 2―3
weeks before the first day of the pollen season.
Therefore, a Cry j 1 level of 1 pgm3 is the suitable
time for medication for patients whose symptoms
start early in the pollen season as well as for the start
of provision of pollen information. It was shown that
about 40% of users of the site “pollen check sheets”
suffered pollinosis symptoms before the first day of
the pollen season. Cry j 1 levels fluctuated at 1 to 3
pgm3 at the time symptoms appeared in some pa-
tients. This point became clear for the first time in the
present study by using a highly-sensitive method
called ESR radical immunoassay. The time of sudden
increase in Cry j 1 levels nearly corresponded to the
time the symptom scores increased. It could confirm
that the time almost corresponded to that of the first
day of the pollen season. We think that the definition
of the first day of the pollen season, which is publi-
cized widely in Japan, should be verified on the basis
of our investigation of airborne Cry j 1 levels.
Lehtimäki et al. reported that sensitive birch
pollen-allergic patients may experience symptoms
when the allergen level reaches about 5 pgm3 of Bet
v 1.13 It was reported that the average amounts of Cry
j 1 in 1 g of JC pollen is about 500 μg14 and the num-
ber of pollen grains in 1 g of JC pollen is approxi-
mately 108. 15 From these values, the amount of Cry j
1 in a pollen grain is calculated as 5 pg. Lehtimäki et
al.’s results for Bet v 1 coincided with ours for Cry j 1.
According to Pehkonen et al.’s report about birch pol-
len antigens,16 large and very small particles pre-
dominate before the pollen season and medium-sized
Takahashi Y et al.
282 Allergology International Vol 56, No3, 2007 www.jsaweb.jp
particles are absent. They concluded that small parti-
cles are also allergologically important.
We showed previously that small particles contain-
ing Cry j 1 existed in the air during the JC pollen sea-
son.17-19 Sagehashi et al. reported that JC pollen re-
leases its allergen in environmental water having a
high ion concentration and to hydrophobic surfaces,
such as diesel exhaust particles (DEP), which consti-
tute pollen allergen-DEP complex generators.20 From
these results, we think that Cry j 1 particles without
pollen in appearance may also contribute to airborne
Cry j 1 sources, especially in high-exposure years as
indicated in Table 3. The total pollen counts and the
total Cry j 1 amounts during the pollen season did not
correlate precisely. The reason is considered to be
that pollen once fallen on the ground whirls up again
and again repeatedly. Some pollen grains collapse
morphologically, and they can not be recognized as
pollen grains any more. It can be thought that the
amounts of Cry j 1 bearing particles differ from year
to year. In addition to these, the amounts of Cry j 1 in
JC pollen grains differ from tree to tree. These are
the causes of the inconsistency between the total pol-
len counts and the total Cry j 1 amounts.
The ESR method is a new technique developed by
the laboratory of the Institute for Life Support Tech-
nology (Matsuei, Yamagata-City, Japan).8-10 Briefly,
an antigen-antibody reaction is performed in the
same manner as in the usual ELISA method on a 96-
well microplate. What is different in the new method
is the use of a stable radical substance as the final
product of the HRP enzyme reaction instead of a sub-
strate for coloration. The discovery of the stable ni-
troxide radical enables the measurement. Radicals
are usually unstable and instantly disappear, but the
nitroxide radical is a stable material living for a day or
two. The existence of the stable radical is a strong
point of the method, because the stable radical only
remains in the solution after the enzyme reaction. No
radicals exist in the solution except for the stable
radical, which makes an extremely high SN ratio
possible and realizes highly-sensitive measurement.
It can be attained with several allergological sub-
stances, such as Der f 2, Dac g and IF-γ (unpublished
data).
In 2005, we started an allergen information service
through the Internet. Pollen allergen information will
be provided in the future. At present, however, infor-
mation is given on the pollen count obtained by mi-
croscopy. The ESR method is extremely useful for
obtaining information before the first day of the pol-
len season. There is a wide difference between pa-
tients’ sensitivity to Cry j 1, though, and by applying
the ESR method to the quantification of Cry j 1,
proper information about the onset time of individual
patients’ symptoms may be delivered through a mo-
bile phone site for those whose past symptom data
have already been accumulated. Measurement of Cry
j 1 by the latex agglutination method21 which we de-
veloped recently will be useful after the first day of
the pollen season. The latter method does not need
any special apparatus, requiring only anti-Cry j 1 poly-
clonal antibody-coated latex beads. The procedure is
simple and easy and takes only 5 minutes each day.
The agglutination reaction requires 2 hours for com-
pletion and therefore, we have to wait 2 hours before
the information can be released. However, the time
lag of 2 hours may be overlooked for information that
is issued at 24-hour intervals. The combination of the
ESR method10 and the latex agglutination method21
will cover the entire pollen season.
It is estimated from Table 3 that we inhale about 15
ng of Cry j 1 during a low-exposure year and 550 ng
or more during a high-exposure year during the JC
pollen season, if an adult is assumed to respire ap-
proximately 10 m3 of air per day. From our past data
of total pollen counts, we speculate that the maximum
levels of Cry j 1 inhaled in a single year in the natural
environment must not exceed 1 μg. The amounts of
Cry j 1 used for animal exposure experiments are ex-
tremely high compared with the amounts of Cry j 1
inhaled naturally. For example, Sakurai et al. exposed
rats to 2 μg Cry j 1 on 5 days per week for 3 months
in a low-dose group and to 20 μg Cry j 1 in a high-
dose group.22 The amounts given in a single day ex-
ceeded those that people inhale during a whole pol-
len season even in a high-exposure year, and this is
without considering the size of rats. However, these
amounts are needed for sensitization of animals in a
short period of time (within 30―60 minutes) in these
experiments, and not all animals are high responders
to the allergens. Pollen exposure units have been
constructed in several countries including Japan (in
Wakayama-City, Osaka-City and Tokyo).23,24 Krug et
al. constructed a pollen exposure unit to study hu-
man inhalation.25 They observed dose-dependent in-
duction of allergic rhinitis symptoms by grass pollen.
Vast numbers of pollen grains are used for the experi-
ments, because concentrations of 1,000―8,000 grains
m3 are reported in dose-dependent induction of aller-
gic symptoms. These concentrations exceed the
high-exposure period in the natural environment.
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